Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 7, 2023ISS recommends voting FOR the re-election of Check-Cap’s director nominees and AGAINST the election of the director nominees put forth by Symetryx
- Feb 7, 2022Company anticipates initiation of first part of pivotal study in the March-April 2022 timeframe
- Nov 22, 2021Patients who underwent the procedure, as part of the 2019 U.S. pilot study, were significantly more likely to recommend C-Scan test compared to colonoscopy
- Nov 2, 2021Patent valid through May 2034
-
Mar 19, 2021Received FDA IDE Approval for Pivotal Study of C-Scan®
- Mar 15, 2021Company expects to commence U.S. pivotal trial in late 2021
- Aug 6, 2020IDE submission to the FDA for C-Scan® planned for the end of 2020; Initiation of a U.S. pivotal study planned for 2021
- May 27, 2020Strengthened balance sheet through a total of $16.3 million in registered direct offerings and a private placement of ordinary shares in the first half of 2020
-
Mar 6, 2020Company planning to initiate a U.S. pivotal study of the C-Scan System in late 2020
-
Dec 30, 2019Advancing towards IDE submission to the FDA, targeting initiation of U.S. pivotal study in late 2020
-
Dec 20, 2019
-
Nov 6, 2019Successfully launched U.S. pilot study and reported positive final results from post-CE approval study of the C-Scan® System
-
Aug 19, 2019GE Healthcare facility in Chicago to support clinical investigation needs of the C-Scan® System in the U.S.
-
Aug 7, 2019Reported positive final results from post-CE approval study of the C-Scan® System
-
Jun 3, 2019Mr. Belkar Brings More Than 20 Years of Global Medical Device Experience, Including at Medtronic and Mazor Robotics
-
May 13, 2019Initiates U.S. pilot study of C-Scan® at NYU School of Medicine and Mayo Clinic
-
May 13, 2019Mayo Clinic joins New York University in pilot study of C-Scan® in the U.S.
-
Dec 13, 2018Study to begin upon review and approval of Institutional Review Board (IRB)
-
Nov 5, 2018Announced Interim Results from Post-CE Approval Study of C-Scan®
-
Oct 9, 2018If Approved, U.S. Pilot Study Anticipated to Commence in 4Q 2018
-
Sep 4, 2018Management to present a corporate overview at the 20th Annual Rodman & Renshaw Global Investment Conference on Wednesday, September 5 at 3:00pm ET
-
Apr 4, 2018Announces the achievement of key validation milestones in C-Scan® system clinical and regulatory pathway
-
Mar 12, 2018Advanced C-Scan Demonstrated Significant Improvement in Average Colon Imaging Coverage in Interim Clinical Evaluation
-
Feb 26, 2018Global Operations and R&D Veteran Brings Focus to C-Scan® Commercial Pathway
-
Jan 10, 2018
-
Dec 5, 2017New Phase Supports C-Scan® Assembly, Testing & Distribution Initially for US Pilot Trial
-
Sep 27, 2017Management Hosts Conference call at 9:00 a.m. EDT
-
May 30, 2017
May 9, 2017Ingestible capsule brings patients one step closer to prep-free, colon screening-
Jan 30, 2017Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual VirtualInvestorConferences.com
-
Jan 17, 2017Preparation-free, capsule-based technology has potential to improve colorectal cancer screening rates
-
Oct 18, 2016- Data presented at the American College of Gastroenterology Annual Scientific Meeting and the United European Gastroenterology Week -
-
Oct 13, 2016- Presentations to take place at the American College of Gastroenterology Annual Scientific Meeting and the United European Gastroenterology Week -